Laurie D. Stelzer, Senior Vice President & Chief Financial Officer

Ms. Stelzer brings to Halozyme an extensive finance and business background. Leading teams in Finance, Treasury, Investor Relations, Business Development and Emerging Markets. Ms. Stelzer joined Halozyme in June 2015 as Senior Vice President, Chief Financial Officer. She is responsible for the Finance, Business Development, Information Technology, Project Management, Facilities and Site Operations organizations.


Prior to Halozyme, Ms. Stelzer served as the Senior Vice President of Finance supporting R&D, Technical Operations and M&A at Shire, Inc. Prior to that she was the Division CFO for the Regenerative Medicine Division and the Head of Investor Relations at Shire. Prior to Shire, Ms. Stelzer held positions of increasing responsibility for 15 years at Amgen, Inc., including Interim Treasurer, Head of Emerging Markets Expansion, Executive Director of Global Commercial Finance and Head of Global Accounting. Early in her career, she held various finance and accounting positions in the real estate and banking industries.


Ms. Stelzer received her B.S. in Accounting from Arizona State University and her MBA from the Anderson School at the University of California, Los Angeles. She is a member of the board of directors for Surface Oncology.


Notice

You are now leaving Halozyme.com. Halozyme is not responsible for or endorses the content of the linked site.

Ok